Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오디펜스(생물방어) 시장 : 제품별, 지역별 - 분석, 점유율, 동향, 규모, 예측(2019-2025년)

Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, & Reagents), & Geography-Analysis, Share, Trends, Size, & Forecast from 2019-2025

리서치사 AnalystView Market Insights
발행일 2019년 12월 상품 코드 918917
페이지 정보 영문 159 Pages
가격
US $ 3,250 ₩ 3,913,000 PDF by E-mail (Single User Licence) help
1명만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 4,650 ₩ 5,598,000 PDF by E-mail (5 User Licence) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. 인쇄 횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,650 ₩ 6,802,000 PDF by E-mail (Enterprise User Licence) help
동일 기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 및 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다.
자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 바이오디펜스(생물방어) 시장 : 제품별, 지역별 - 분석, 점유율, 동향, 규모, 예측(2019-2025년) Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, & Reagents), & Geography-Analysis, Share, Trends, Size, & Forecast from 2019-2025
발행일 : 2019년 12월 페이지 정보 : 영문 159 Pages

세계의 바이오디펜스(Biodefense : 생물방어) 시장은 2018년에 54억 2,000만 달러를 기록했습니다. 이 시장은 2019-2025년 4.8%의 CAGR로 성장할 것으로 예측되고 있습니다. 생물학적 위협에 대한 적극적인 정부의 구상은 이 시장의 성장을 촉진하는 요인입니다.

세계의 바이오디펜스 시장에 대해 조사했으며, 시장 기회 및 동향, 성장 및 저해요인, 제품·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 시장 개요

  • 조사 범위
  • 전제조건

제2장 개요

  • 시장 부문
    • 제품별
    • 지역별
  • 경쟁 구도

제3장 주요 시장 동향

  • 시장 성장 촉진요인
    • 영향 분석
  • 시장 성장 저해요인
    • 영향 분석
  • 시장 기회
  • 시장의 향후 동향

제4장 산업 조사

  • Porter의 산업 분석
  • 마케팅 전략 분석
  • 성장 전망 지도제작
  • 규제 프레임워크 분석

제5장 시장 현황

  • 시장 점유율 분석
  • 주요 이노베이터
  • 주요 제조업체별 : 내역 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제6장 시장 분석 : 제품별

  • 개요
    • 부문 점유율 분석
  • 백신
    • 개요
    • 시장 분석, 예측, 전년대비 성장률
    • 천연두
    • 탄저병
    • 방사선/핵
    • 보툴리눔독소증
  • 생물 위협 검출 디바이스
    • 개요
    • 시장 분석, 예측, 전년대비 성장률
    • 샘플러
    • 식별자
    • 어세이
    • 시약
    • 검출기/트리거 디바이스

제7장 시장 분석 : 지역별

  • 서론
    • 부문 점유율 분석
  • 북미
    • 개요
    • 주요 제조업체
    • 시장 규모·예측 : 국가별
    • 시장 규모·예측 : 제품별
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 기타
  • 아시아태평양(APAC)
    • 인도
    • 중국
    • 일본
    • 한국
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타
  • 중동·아프리카
    • 사우디아라비아
    • 아랍에미리트

제8장 주요 벤더 분석

  • Dynavax Technologies
    • 기업 현황
    • 재무 실적
    • 제품 벤치마킹
    • 전략적 구상
  • Xoma Corporation
  • Emergent BioSolutions, Inc.
  • SIGA Technologies, Inc.
  • PharmAthene, Inc.
  • Elusys Therapeutics, Inc.
  • Dynport Vaccine Company
  • Bavarian Nordic
  • Ichor Medical Systems
  • Cleveland Biolabs
  • Nanotherapeutics, Inc.
  • Achaogen, Inc.
  • Alnylam Pharmaceuticals, Inc.

제9장 전방위적 분석

제10장 부록

  • 조사 방법
  • 참조 자료
  • 약어
  • 면책사항
  • 문의
KSA 20.01.06

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Figures

  • FIGURE Biodefense market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Product segment market share analysis, 2018 & 2025
  • FIGURE Product segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Vaccines market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Smallpox market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Anthrax market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Radiation/Nuclear market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Botulism market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Biothreat Detection Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Samplers market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Identifiers market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Assays market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Reagents market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Detectors/Triggering Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Regional segment market share analysis, 2018 & 2025
  • FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE North America Biodefense market share and leading players, 2018
  • FIGURE Europe Biodefense market share and leading players, 2018
  • FIGURE Asia Pacific Biodefense market share and leading players, 2018
  • FIGURE Latin America Biodefense market share and leading players, 2018
  • FIGURE Middle East and Africa Biodefense market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Europe market share analysis by country, 2018
  • FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Spain market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Italy market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE UK market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE France market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Asia Pacific market share analysis by country, 2018
  • FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Japan market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE South Korea market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Singapore market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of APAC market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Latin America market share analysis by country, 2018
  • FIGURE Brazil market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Mexico market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Argentina market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of LATAM market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market share analysis by country, 2018
  • FIGURE Saudi Arabia market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE United Arab Emirates market size, forecast and trend analysis, 2014 to 2025 (USD Million)

REPORT HIGHLIGHT

Biodefense Market was valued at USD 5.42 billion by 2018, growing with 4.8% CAGR during the forecast period, 2019-2025

MARKET DYNAMICS

Biodefense is defined as the actions designed to counter biological threats, and prepare to respond bio-incidents. It also refers to the short term, usually military measures to restore biosecurity. Biodefense constitutes the use of medical measures in order to protect individuals against bioterrorism. Biodefense applied to two distinct target populations that are military combatant (troops in the field), and civilian non-combatant.

The market growth is majorly driven by favorable government initiatives. Organizations such as Centers for Disease Control and Prevention (CDC), the Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), and the United States Department of Health & Human Services (HHS) are actively working towards medical countermeasures against such biological threats. Such initiatives would, in turn, support the market growth to a great extent. However, strict regulations coupled with high barriers to entry will hamper the market growth to some extent.

PRODUCT TAKEAWAY

The product segment is broadly classified into vaccines and biothreat detection devices. Vaccine products are further divided into Smallpox, Anthrax, Radiation/nuclear, Botulism, and others. Anthrax and smallpox are amongst the key areas for R&D activities due to their high potential for destruction. These products are continuing to command the attention of many governments globally, accounting for a significant share of the worldwide market. Of these, anthrax captured the highest revenue share, i.e. over 30% in 2018 owing to the rising investments by the U.S. government for mitigating the anthrax bioterrorism risk. Currently, Anthrax Vaccine Adsorbed (AVA) is the only U.S. FDA licensed anthrax vaccine, commercially available under BioThrax trade name in the U.S. market.

Whereas, biothreat detection devices segment is categorized into detectors/triggering devices, samplers, identifiers, assays, and reagents. Biodefense samplers are primarily used to facilitate biological sampling as well as for the transport packaging, reducing waste and speeding up sampling time.

REGIONAL TAKEAWAY

North America captured the highest share (more than 70%) of the worldwide biodefense market. Rising financial support by the U.S. military and civilian agencies for R&D activities coupled with favorable government policies support the regional growth. For instance, the U.S. government has taken steps to implement an enterprise approach and integrated strategy to combat biological threats. In September 2018. U.S. President Donald J. Trump has suggested implementing a National Biodefense Strategy to effectively prepare for fighting biological threats.

On the other side, developing regions such as the Asia Pacific accounts for significant revenue share. Regional growth is majorly attributed to the rising government support coupled with the growing number of conferences on biosafety. For instance, in September 2019, Asia Pacific Biosafety Association (A-PBA) has organized the 14th Annual Biorisk Conference in Dhaka, Bangladesh. This conference was aimed to discuss proactive steps on biosafety and biosecurity for the sustainable development of a region in the healthcare and agricultural sectors.

KEY VENDORS TAKEAWAY

Key players operating in the global biodefense market include Achaogen, Inc., Xoma Corporation, Emergent BioSolutions, Inc., SIGA Technologies, Inc., PharmAthene, Inc., Elusys Therapeutics, Inc., Dynavax Technologies, Ichor Medical Systems, Cleveland Biolabs, Dynport Vaccine Company, Nanotherapeutics, Inc., Bavarian Nordic, and Alnylam Pharmaceuticals, Inc.

Companies are actively engaged in mergers and acquisitions to expand their presence in the biodefense industry. For instance, a biopharmaceutical company, "Altimmune" acquired PharmAthene, Inc., a biodefense firm in May 2017. This collaboration is aimed to create a new immunotherapy company focused on developing products for infectious diseases such as anthrax. Such activities would, in turn, help key players to expand their presence in this industry.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

  • Dynavax Technologies
  • Xoma Corporation
  • Emergent BioSolutions, Inc.
  • SIGA Technologies, Inc.
  • PharmAthene, Inc.
  • Elusys Therapeutics, Inc.
  • Dynport Vaccine Company
  • Bavarian Nordic
  • Ichor Medical Systems
  • Cleveland Biolabs
  • Nanotherapeutics, Inc.
  • Achaogen, Inc.
  • Alnylam Pharmaceuticals, Inc.

MARKET, BY PRODUCT

  • Vaccines
  • Smallpox
  • Anthrax
  • Radiation/Nuclear
  • Botulism
  • Biothreat Detection Devices
  • Samplers
  • Identifiers
  • Assays
  • Reagents
  • Detectors/Triggering Devices

MARKET, BY REGION

  • North America
  • S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1.BIODEFENSE MARKET OVERVIEW

  • 1.1.Study Scope
  • 1.2.Assumption and Methodology

2.EXECUTIVE SUMMARY

  • 2.1.Market Snippet
    • 2.1.1.Market Snippet by Product
    • 2.1.2.Market Snippet by Region
  • 2.2.Competitive Insights

3.BIODEFENSE KEY MARKET TRENDS

  • 3.1.Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Market Opportunities
  • 3.4.Market Future Trends

4.BIODEFENSE INDUSTRY STUDY

  • 4.1.Porter's Five Forces Analysis
  • 4.2.Marketing Strategy Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.BIODEFENSE MARKET LANDSCAPE

  • 5.1.Market Share Analysis
  • 5.2.Key Innovators
  • 5.3.Breakdown Data, by Key manufacturer
    • 5.3.1.Established Player Analysis
    • 5.3.2.Emerging Player Analysis

6.BIODEFENSE MARKET - BY PRODUCT

  • 6.1.Overview
    • 6.1.1.Segment Share Analysis, By Product, 2018 & 2025 (%)
  • 6.2.Vaccines
    • 6.2.1.Overview
    • 6.2.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.3.Smallpox
      • 6.2.3.1.Overview
      • 6.2.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.4.Anthrax
      • 6.2.4.1.Overview
      • 6.2.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.5.Radiation/Nuclear
      • 6.2.5.1.Overview
      • 6.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.6.Botulism
      • 6.2.6.1.Overview
      • 6.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3.Biothreat Detection Devices
    • 6.3.1.Overview
    • 6.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.3.Samplers
      • 6.3.3.1.Overview
      • 6.3.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.4.Identifiers
      • 6.3.4.1.Overview
      • 6.3.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.5.Assays
      • 6.3.5.1.Overview
      • 6.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.6.Reagents
      • 6.3.6.1.Overview
      • 6.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.7.Detectors/Triggering Devices
      • 6.3.7.1.Overview
      • 6.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7.BIODEFENSE MARKET- BY GEOGRAPHY

  • 7.1.Introduction
    • 7.1.1.Segment Share Analysis, By Region, 2018 & 2025 (%)
  • 7.2.North America
    • 7.2.1.Overview
    • 7.2.2.Key Manufacturers in North America
    • 7.2.3.North America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.2.4.North America Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.2.5.U.S.
      • 7.2.5.1.Overview
      • 7.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.2.6.Canada
      • 7.2.6.1.Overview
      • 7.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3.Europe
    • 7.3.1.Overview
    • 7.3.2.Key Manufacturers in Europe
    • 7.3.3.Europe Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.3.4.Europe Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.3.5.Germany
      • 7.3.5.1.Overview
      • 7.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.6.Italy
      • 7.3.6.1.Overview
      • 7.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.7.United Kingdom
      • 7.3.7.1.Overview
      • 7.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.8.France
      • 7.3.8.1.Overview
      • 7.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.9.Rest of Europe
      • 7.3.9.1.Overview
      • 7.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4.Asia Pacific (APAC)
    • 7.4.1.Overview
    • 7.4.2.Key Manufacturers in Asia Pacific
    • 7.4.3.Asia Pacific Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.4.4.Asia Pacific Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.4.5.India
      • 7.4.5.1.Overview
      • 7.4.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.6.China
      • 7.4.6.1.Overview
      • 7.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.7.Japan
      • 7.4.7.1.Overview
      • 7.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.8.South Korea
      • 7.4.8.1.Overview
      • 7.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.9.Rest of APAC
      • 7.4.9.1.Overview
      • 7.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5.Latin America
    • 7.5.1.Overview
    • 7.5.2.Key Manufacturers in Latin America
    • 7.5.3.Latin America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.5.4.Latin America Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.5.5.Brazil
      • 7.5.5.1.Overview
      • 7.5.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.6.Mexico
      • 7.5.6.1.Overview
      • 7.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.7.Argentina
      • 7.5.7.1.Overview
      • 7.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.8.Rest of LATAM
      • 7.5.8.1.Overview
      • 7.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.6.Middle East and Africa
    • 7.6.1.Overview
    • 7.6.2.Key Manufacturers in Middle East and Africa
    • 7.6.3.Middle East and Africa Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.6.4.Middle East and Africa Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.6.5.Saudi Arabia
      • 7.6.5.1.Overview
      • 7.6.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.6.6.United Arab Emirates
      • 7.6.6.1.Overview
      • 7.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8.KEY VENDOR ANALYSIS

  • 8.1.Dynavax Technologies
    • 8.1.1.Company Snapshot
    • 8.1.2.Financial Performance
    • 8.1.3.Product Benchmarking
    • 8.1.4.Strategic Initiatives
  • 8.2.Xoma Corporation
  • 8.3.Emergent BioSolutions, Inc.
  • 8.4.SIGA Technologies, Inc.
  • 8.5.PharmAthene, Inc.
  • 8.6.Elusys Therapeutics, Inc.
  • 8.7.Dynport Vaccine Company
  • 8.8.Bavarian Nordic
  • 8.9.Ichor Medical Systems
  • 8.10.Cleveland Biolabs
  • 8.11.Nanotherapeutics, Inc.
  • 8.12.Achaogen, Inc.
  • 8.13.Alnylam Pharmaceuticals, Inc.

9.360 DEGREE ANALYSTVIEW

10.APPENDIX

  • 10.1.Research Methodology
  • 10.2.References
  • 10.3.Abbreviations
  • 10.4.Disclaimer
  • 10.5.Contact Us
Back to Top
전화 문의
F A Q